U.S. Consumer Services Stock News

Earlier this month, PTC Therapeutics reported third quarter 2025 earnings, posting US$211.01 million in revenue and a net income of US$15.9 million, compared to a net loss a year earlier, and also narrowed its full-year revenue guidance to US$750 million to US$800 million. This marked a sharp turnaround in profitability for the company, highlighting improved operational performance and signaling a shift from persistent losses to positive quarterly earnings. We'll examine how PTC...

Evercore (EVR) has just brought Keith Prusek and Hugh Rabb on board as senior managing directors in its transportation investment banking group. This move marks the opening of a new office in Richmond, Virginia and signals fresh momentum in its expansion strategy. See our latest analysis for Evercore. With this leadership shakeup and a new Richmond office, Evercore’s momentum is turning heads. The share price is up 11.4% year-to-date, and while the 1-year total shareholder return is a modest...

Autodesk (ADSK) stock has been relatively steady with slight movements over the past week. This has attracted attention from investors who are looking for updates on its growth story. Many are watching how its recent growth trends might influence upcoming quarters. See our latest analysis for Autodesk. Autodesk’s stock has posted a modest share price return year to date, and while short-term moves have been mild, its total shareholder return over the past three years sits at an impressive...

Spyre Therapeutics (SYRE) drew attention after releasing encouraging interim results from its Phase 1 trial of SPY003, in addition to reporting a substantial year-over-year improvement in both quarterly and nine-month net losses. See our latest analysis for Spyre Therapeutics. On the heels of upbeat clinical trial news and a slimmer quarterly net loss, Spyre Therapeutics has seen momentum pick up, with a recent 90-day share price return of 38.7%. However, despite these gains, the one-year...

Lamar Advertising (LAMR) just posted its third quarter earnings, revealing higher sales than the same period last year, although net income slipped a bit for the quarter. For the first nine months, both sales and net income were up compared to 2024. See our latest analysis for Lamar Advertising. Following this earnings update, Lamar Advertising’s share price has gained momentum, delivering an 8.9% return over the past month and building steadily throughout the year. Long-term investors have...

Cencora recently announced plans to expand its pharmaceutical distribution network across the U.S., including opening new advanced distribution centers in Ohio and California, and greatly increasing specialty medicine storage capacity in Alabama, all with a focus on automation and growing specialty drug demand. This expansion comes as the company reported higher full-year sales and net income, a quarterly loss caused by a substantial goodwill impairment, and a 9% increase in its quarterly...

Abaxx Technologies (OTCPK:ABXX.F) has been in the spotlight following two key moves: a partnership with ARTEX AG to modernize asset trading and the launch of the Enwex German Wind Futures contract. These developments highlight Abaxx's expanding global reach and focus on market infrastructure innovation. See our latest analysis for Abaxx Technologies. After a year of eye-catching developments, Abaxx Technologies is drawing more attention from growth-minded investors. The 237.5% year-to-date...

Wondering if Artisan Partners Asset Management is undervalued, overhyped, or flying under the radar? You are not alone, since finding true value in a market crowded with asset managers is rarely straightforward. The stock has delivered stable long-term growth, up 56.4% over the past three years and 42.1% over five years, but it has dipped -5.8% over the past week and -2.1% for the past month. This signals that the market’s sentiment is anything but settled right now. This recent price...

Lionsgate Studios (LION) stock has been attracting some renewed interest lately, particularly after its recent earnings report. Investors are weighing how the company’s strategy might influence results in the months ahead, especially as streaming dynamics continue to shift. See our latest analysis for Lionsgate Studios. After a turbulent start to the year, Lionsgate Studios’ share price has recently shown some signs of momentum, climbing 12.35% over the past month and 5.40% in the last...

Tennant (TNC) reported quarterly sales and earnings below last year’s results, with net income for the past nine months falling as well. The company reaffirmed annual guidance, highlighting persistent headwinds and continued pressure on demand. See our latest analysis for Tennant. After reaffirming guidance and reporting lower sales, Tennant’s share price has lost momentum, falling 9.27% over the past month and now posting a 1-year total shareholder return of -15.07%. Despite long-term gains...

Earlier this month, HubSpot reported third quarter results showing revenue of US$809.52 million and net income of US$16.54 million, while also appointing Clara Shih, Meta’s Head of Business AI Group, to its Board of Directors. The combination of analyst downgrades, concerns about AI disruption, and leadership changes highlights both market skepticism and HubSpot's drive to enhance its AI capabilities. To assess the implications for HubSpot’s investment case, we’ll explore how Clara Shih’s...

Hut 8 (NasdaqGS:HUT) shares have caught attention following a recent change in performance metrics. Investors are taking stock of the company’s returns, especially as the stock jumped 3% on the day after shifting trends earlier this month. See our latest analysis for Hut 8. After a rough patch earlier this month, Hut 8’s 1-day share price return of 2.55% signals momentum may be picking up again, even though the 7-day and 30-day share price returns remain negative. Looking at the bigger...

Biohaven (NYSE:BHVN) just completed a $175 million follow-on public offering, issuing new shares at $7.50, which is lower than its prior trading price. This move is aimed at bolstering the company’s balance sheet after recent challenges. See our latest analysis for Biohaven. Biohaven’s recent stock performance has been dominated by sharp moves, most notably a roughly 48% drop in the last three months after the FDA declined to approve its experimental drug. This led to a follow-on stock...

On November 11, 2025, LXP Industrial Trust executed a 1-for-5 stock split, adjusting its share structure to issue one new share for every five previously held. This type of reverse stock split is relatively uncommon among REITs and can shape investor sentiment by adjusting both share price and market perceptions of the company's positioning. We’ll examine how the reverse stock split may influence LXP’s investment narrative, especially given its effect on share structure and investor...

SoundHound AI (SOUN) has been catching the attention of investors lately, partly due to recent changes in its stock price and ongoing shifts in the artificial intelligence sector. Many are now watching to see how these movements might influence the company’s future outlook. See our latest analysis for SoundHound AI. It has been a volatile stretch for SoundHound AI, with the share price retracing 36% over the past month and momentum clearly fading after a red-hot run. Yet, the company’s...

Genworth Financial (GNW) just posted third quarter results that showed both revenue and net income increased compared to last year. The company also completed a large share buyback program, which may catch the attention of investors. See our latest analysis for Genworth Financial. Genworth Financial's steady year-to-date share price return of 22.21% suggests momentum is still in investors' favor, especially following the recent earnings beat and the completion of a major buyback program. The...

Vera Therapeutics (VERA) is drawing fresh attention after announcing positive Phase 3 results for atacicept in IgA nephropathy and submitting a Biologics License Application to the FDA. In addition, Yale University's recent investment adds another layer of institutional confidence. See our latest analysis for Vera Therapeutics. Vera Therapeutics has seen investor sentiment turn sharply in recent weeks, with momentum building around positive clinical milestones and a new FDA submission...

Grocery Outlet Holding (GO) revised its 2025 outlook, narrowing its net sales guidance and lowering projections for comparable store sales growth. The company also reported quarterly earnings that showed increased sales, while net income experienced a sharp year-over-year decline. See our latest analysis for Grocery Outlet Holding. Following the guidance cut and a sharp drop in quarterly earnings, Grocery Outlet's recent events have weighed on sentiment, even as the company announced a...

KeyCorp (KEY) has caught the interest of investors lately, as its share price has shifted in tandem with changing market trends. The bank’s recent performance invites a closer look at how its fundamentals compare. See our latest analysis for KeyCorp. KeyCorp's share price has moved with the market's mood swings over the past year, recently closing at $17.62. While short-term momentum has softened after a modest 30-day gain, its one-year total shareholder return remains slightly negative. This...

Bank of New York Mellon (BK) shares have seen noticeable movement over the past month, gaining roughly 4% and building on a strong performance so far this year. Investors are weighing the bank’s solid revenue and net income growth trends. See our latest analysis for Bank of New York Mellon. Bank of New York Mellon's share price has climbed about 43% so far this year, reflecting solid momentum as investors take note of the bank’s execution and consistent earnings growth. Its 1-year total...

Vital Farms (VITL) just delivered impressive third quarter results, with both sales and net income seeing substantial year-over-year growth. The company also raised its full-year revenue guidance, which highlights ongoing momentum and confidence in future performance. See our latest analysis for Vital Farms. Despite posting big jumps in sales and profit, plus raising its outlook, Vital Farms’ share price is down 20% over the past month and 33% over the last quarter. Still, investors who have...

Helmerich & Payne released its fourth quarter earnings results after the market closed on November 17, with analysts having anticipated a significant decrease in profits compared to the previous year. The company's dividend yield of 3.71% remains a focal point for investors seeking steady income amid profit uncertainty. To understand how heightened earnings risk and income focus impact Helmerich & Payne’s outlook, we’ll review the company’s investment narrative. AI is about to change...

Ocular Therapeutix recently announced that its SOL-R registrational trial for AXPAXLI in wet age-related macular degeneration successfully reached its enrollment target of 555 subjects and reported third-quarter revenue of US$14.54 million, with a net loss of US$69.42 million for the same period. This milestone in late-stage clinical development highlights strong momentum in Ocular Therapeutix's ophthalmology pipeline despite a period of widening losses. We'll now consider how achieving the...

In the past week, several analysts maintained neutral ratings for Invitation Homes but lowered their price targets, signaling increased caution toward the company amid ongoing housing market pressures. This cautious analyst outlook emerged even though Invitation Homes delivered third-quarter results that matched expectations and continues to focus on operational efficiency and high-demand regional markets. We'll examine how the wave of analyst caution and price target revisions affects the...